These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38581326)

  • 1. Analysis of the Predictive Efficacy of Serum suPAR Combined with APN and IgE Test and the Relationship of Patients with CHF and Cardiac Function.
    Tu S; Ye L; Shen C; Bai X; Li C
    Altern Ther Health Med; 2024 Apr; 30(4):124-129. PubMed ID: 38581326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure.
    Jirak P; Fejzic D; Paar V; Wernly B; Pistulli R; Rohm I; Jung C; Hoppe UC; Schulze PC; Lichtenauer M; Yilmaz A; Kretzschmar D
    Acta Pharmacol Sin; 2018 Jul; 39(7):1189-1196. PubMed ID: 29239349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure.
    Koller L; Stojkovic S; Richter B; Sulzgruber P; Potolidis C; Liebhart F; Mörtl D; Berger R; Goliasch G; Wojta J; Hülsmann M; Niessner A
    JACC Heart Fail; 2017 Apr; 5(4):268-277. PubMed ID: 28359415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble urokinase-type plasminogen activator receptor represents exercise tolerance and predicts adverse cardiac events in patients with heart failure.
    Ishikawa H; Izumiya Y; Shibata A; Ichikawa Y; Yamaguchi T; Yamaguchi Y; Kitada R; Iwata S; Ehara S; Tomita S; Hanatani A; Yoshiyama M
    Heart Vessels; 2020 May; 35(5):681-688. PubMed ID: 31741050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinally Measured Fibrinolysis Factors are Strong Predictors of Clinical Outcome in Patients with Chronic Heart Failure: The Bio-SHiFT Study.
    van den Berg VJ; Bouwens E; Umans VAWM; de Maat M; Manintveld OC; Caliskan K; Constantinescu AA; Mouthaan H; Cornel JH; Baart S; Akkerhuis KM; Boersma E; Kardys I
    Thromb Haemost; 2019 Dec; 119(12):1947-1955. PubMed ID: 31659734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. suPAR level is associated with myocardial impairment assessed with advanced echocardiography in patients with type 1 diabetes with normal ejection fraction and without known heart disease or end-stage renal disease.
    Theilade S; Rossing P; Eugen-Olsen J; Jensen JS; Jensen MT
    Eur J Endocrinol; 2016 Jun; 174(6):745-53. PubMed ID: 26951602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study.
    Jalkanen V; Vaahersalo J; Pettilä V; Kurola J; Varpula T; Tiainen M; Huhtala H; Alaspää A; Hovilehto S; Kiviniemi O; Kuitunen A; Tenhunen J;
    Resuscitation; 2014 Nov; 85(11):1562-7. PubMed ID: 25193800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble urokinase plasminogen activator receptor as a long-term prognostic biomarker in acute coronary syndromes.
    Peiró ÓM; Cediel G; Bonet G; Rojas S; Quintern V; Carrasquer A; González-Del-Hoyo M; Sanz E; Bardají A
    Biomarkers; 2020 Jul; 25(5):402-409. PubMed ID: 32551985
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnostic Value of Biochemical Markers in Patients With Chronic Heart Failure With Reduced, Borderline and Preserved Left Ventricular Ejection Fraction].
    Bazaeva EV; Myasnikov RP; Metelskaya VA; Boytsov SA
    Kardiologiia; 2017 Mar; 57(3):39-45. PubMed ID: 28762934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative analysis of novel cardiovascular biomarkers in patients with chronic heart failure.
    Lichtenauer M; Jirak P; Wernly B; Paar V; Rohm I; Jung C; Schernthaner C; Kraus J; Motloch LJ; Yilmaz A; Hoppe UC; Christian Schulze P; Kretzschmar D; Pistulli R
    Eur J Intern Med; 2017 Oct; 44():31-38. PubMed ID: 28579310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated with Low Left Ventricular Ejection Fraction and Elevated Plasma Brain-Type Natriuretic Peptide Level.
    Fujita SI; Tanaka S; Maeda D; Morita H; Fujisaka T; Takeda Y; Ito T; Ishizaka N
    PLoS One; 2017; 12(1):e0170546. PubMed ID: 28135310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study.
    Luo Q; Ning P; Zheng Y; Shang Y; Zhou B; Gao Z
    Crit Care; 2018 Jan; 22(1):15. PubMed ID: 29368632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between suPAR and cardiac diastolic dysfunction among patients with preserved ejection fraction.
    Fujisaka T; Fujita SI; Maeda D; Shibata K; Takahashi H; Morita H; Takeda Y; Ito T; Sohmiya K; Hoshiga M; Ishizaka N
    Heart Vessels; 2017 Nov; 32(11):1327-1336. PubMed ID: 28589505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of heart rate turbulence parameters in patients with chronic heart failure.
    Yin DC; Wang ZJ; Guo S; Xie HY; Sun L; Feng W; Qiu W; Qu XF
    BMC Cardiovasc Disord; 2014 Apr; 14():50. PubMed ID: 24725657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of soluble Fas ligand in myocardial remodeling, severity and outcomes of chronic heart failure].
    Teplyakov AT; Berezikova EN; Shilov SN; Grakova EV; Torim YY; Efremov AV; Popova AA; Pustovetova MG; Sabirova AY; Kopyeva KV
    Ter Arkh; 2016; 88(9):10-16. PubMed ID: 27735908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of brain natriuretic peptide and serum triiodothyronine in the diagnosis and prognosis of chronic heart failure.
    Du JB; Da CH; Zhao Y; Guo Y; Guo G; Ju TF; Xu YP
    Acta Cardiol; 2012 Jun; 67(3):291-6. PubMed ID: 22870736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia in chronic heart failure patients: comparison between invasive and non-invasive prognostic markers.
    Ceresa M; Capomolla S; Pinna G; Aiolfi E; La Rovere MT; Febo O; Paganini V; Rossi A; Guazzotti G; Caporotondi A; Maestri R; Cobelli F
    Monaldi Arch Chest Dis; 2005 Jun; 64(2):124-33. PubMed ID: 16499298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of plasma ghrelin in predicting the outcome of patients with chronic heart failure.
    Chen Y; Ji XW; Zhang AY; Lv JC; Zhang JG; Zhao CH
    Arch Med Res; 2014 Apr; 45(3):263-9. PubMed ID: 24508287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can soluble urokinase plasminogen receptor predict outcomes after cardiac surgery?
    Schultz-Swarthfigure CT; McCall P; Docking R; Galley HF; Shelley B
    Interact Cardiovasc Thorac Surg; 2021 Jan; 32(2):236-243. PubMed ID: 33236082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
    Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
    Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.